Zhuxia Zhang, Bingxuan Xu, Tao Lv, Yu Shi, Mengxin Wang, Die Hu, Azhen Hu, Ping Li, Shuping Lin, Shengwei Zhang, Rongquan Yao, Lan Luo, Linlin Wang, Yiping Zhang, Yanni Han, Huiying Hu, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng
{"title":"皂苷包裹的微泡保护多巴胺能神经元免受MPTP诱导的氧化应激损伤(Adv.Therap.10/2023)","authors":"Zhuxia Zhang, Bingxuan Xu, Tao Lv, Yu Shi, Mengxin Wang, Die Hu, Azhen Hu, Ping Li, Shuping Lin, Shengwei Zhang, Rongquan Yao, Lan Luo, Linlin Wang, Yiping Zhang, Yanni Han, Huiying Hu, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng","doi":"10.1002/adtp.202370027","DOIUrl":null,"url":null,"abstract":"<p>Ginsenoside Rb<sub>3</sub> nanoparticles (Rb<sub>3</sub>NPs) is a potential antioxidant for Parkinson's disease (PD) treatment. In Article 2300056, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng, and co-workers introduce phospholipid microbubbles encapsulated Rb<sub>3</sub>NPs (Rb<sub>3</sub>NPs@MBs) with low intensity low frequency focused ultrasound to achieve brain targeted Rb<sub>3</sub>NPs drug release. The treatment protects neurons from oxidative damage and slows PD progression. The article shows a perfect combination of traditional Chinese medicine with modern medical research in PD treatment.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"6 10","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.202370027","citationCount":"0","resultStr":"{\"title\":\"Saponin-Encapsulated Microbubbles Protect Dopaminergic Neurons from MPTP-Induced Oxidative Stress Injury (Adv. Therap. 10/2023)\",\"authors\":\"Zhuxia Zhang, Bingxuan Xu, Tao Lv, Yu Shi, Mengxin Wang, Die Hu, Azhen Hu, Ping Li, Shuping Lin, Shengwei Zhang, Rongquan Yao, Lan Luo, Linlin Wang, Yiping Zhang, Yanni Han, Huiying Hu, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng\",\"doi\":\"10.1002/adtp.202370027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Ginsenoside Rb<sub>3</sub> nanoparticles (Rb<sub>3</sub>NPs) is a potential antioxidant for Parkinson's disease (PD) treatment. In Article 2300056, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng, and co-workers introduce phospholipid microbubbles encapsulated Rb<sub>3</sub>NPs (Rb<sub>3</sub>NPs@MBs) with low intensity low frequency focused ultrasound to achieve brain targeted Rb<sub>3</sub>NPs drug release. The treatment protects neurons from oxidative damage and slows PD progression. The article shows a perfect combination of traditional Chinese medicine with modern medical research in PD treatment.\\n\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":7284,\"journal\":{\"name\":\"Advanced Therapeutics\",\"volume\":\"6 10\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2023-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.202370027\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adtp.202370027\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adtp.202370027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Ginsenoside Rb3 nanoparticles (Rb3NPs) is a potential antioxidant for Parkinson's disease (PD) treatment. In Article 2300056, Xintao Shuai, Jie Shi, Yun Chen, Tingting Zheng, and co-workers introduce phospholipid microbubbles encapsulated Rb3NPs (Rb3NPs@MBs) with low intensity low frequency focused ultrasound to achieve brain targeted Rb3NPs drug release. The treatment protects neurons from oxidative damage and slows PD progression. The article shows a perfect combination of traditional Chinese medicine with modern medical research in PD treatment.